Abstract

This study aims at assessing the efficacy of COVID-19 mitigation strategies on incidence. It examines the efficacy of the test-trace-isolate-quarantine (TTIQ) strategy in the containment of COVID-19 pandemic to determine the role of the environment in the pandemic and to recommend appropriate practices in the management of COVID-19 outbreak in terms of contact tracing, screening, quarantine, and isolation. To achieve these objectives, the study uses the systematic literature review, whereby secondary data is utilised to address the problem. The study findings show that TTIQ is the best practice for application by medical healthcare practitioners to treat COVID-19 cases worldwide. The TTIQ approach positively impacts the efforts to contain the virus due to the structured measures and practices utilized in dealing with the pandemic. However, the specific characteristics of the environment such as the presence of the supporting healthcare practitioners, defined procedures for minimal interactions and the general application of the related best practices affect the outcome of the exercise and the effectiveness of the TTIQ. In the same way, the presence of qualified practitioners is critical in delivering the required guidelines and expected outcomes towards the containment of the virus. Consequently, the efforts to improve environmental characteristics significantly help in achieving the best outcomes in containing the virus by introducing the cases of infection and achieving high-quality care for infected patients. The need to embrace solutions that minimize the physical interactions and improve the efficacy of the strategies of the management of the pandemic necessitated the adoption of the digital solutions; which mainly consisted of the mobile app solutions and the website technologies to support the strategies implemented to the population.

References

1. Alimohamadi, Y., Sepandi, M., Taghdir, M. and Hosamirudsari, H., 2020. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. Journal of Preventive Medicine and Hygiene, 61(3), p.E304.
2. Andrews, P.L., Cai, W., Rudd, J.A. and Sanger, G.J., 2021. COVID‐19, nausea, and vomiting. Journal of Gastroenterology and Hepatology, 36(3), pp.646-656.
3. Ashcroft, P., Lehtinen, S. and Bonhoeffer, S., 2022. Test-trace-isolate-quarantine (TTIQ) intervention strategies after symptomatic COVID-19 case identification. PloS one, 17(2), p.e0263597.
4. Ayoubkhani, D. and Pawelek, P., 2021. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. Off Natl Stat, pp.1-16.
5. Bauchner, H. and Fontanarosa, P.B., 2020. Randomised clinical trials and COVID-19: managing expectations. JAMA, 323(22), pp.2262-2263.
6. Braun, V. and Clarke, V., 2019. Reflecting on reflexive thematic analysis. Qualitative Research in Sport, Exercise and Health, 11(4), pp.589-597.
7. Cao, X., 2020. COVID-19: immunopathology and its implications for therapy. Nature Reviews Immunology, 20(5), pp.269-270.
8. Carfì, A., Bernabei, R. and Landi, F., 2020. Persistent symptoms in patients after acute COVID-19. JAMA, 324(6), pp.603-605.
9. Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.C., Wang, C.B. and Bernardini, S., 2020. The COVID-19 pandemic. Critical Reviews in Clinical Laboratory Sciences, 57(6), pp.365-388.
10. Clarke, V., Braun, V. and Hayfield, N., 2015. Thematic analysis. Qualitative psychology: A practical guide to research methods, 222(2015), p.248.
11. Conway, E., Walker, C., Baker, C., Lydeamore, M., Ryan, G.E., Campbell, T., Miller, J.C., Yeung, M., Kabashima, G., Wood, J. and Rebuli, N., 2022. COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting. medRxiv.
12. Cunningham, A.C., Goh, H.P. and Koh, D., 2020. Treatment of COVID-19: old tricks for new challenges. Critical Care, 24(1), pp.1-2.
13. Daniel, S.J., 2020. Education and the COVID-19 pandemic. Prospects, 49(1), pp.91-96.
14. Dowthwaite, L., Fischer, J., Vallejos, E.P., Portillo, V., Nichele, E., Goulden, M. and McAuley, D., 2021. Public adoption of and trust in the NHS COVID-19 contact tracing app in the United Kingdom: quantitative online survey study. Journal of Medical Internet Research, 23(9), p.e29085.
15. Elibol, E., 2021. Otolaryngological symptoms in COVID-19. European Archives of Oto-Rhino-Laryngology, 278(4), pp.1233-1236.
16. Eloranta, V. and Turunen, T., 2015. Seeking competitive advantage with service infusion: a systematic literature review. Journal of Service Management.
17. Fauci, A.S., Lane, H.C. and Redfield, R.R., 2020. COVID-19 navigating the uncharted. New England Journal of Medicine, 382(13), pp.1268-1269.
18. Feng, L.X., Jing, S.L., Hu, S.K., Wang, D.F. and Huo, H.F., 2020. Modelling the effects of media coverage and quarantine on the COVID-19 infections in the UK. Math Biosci Eng, 17(4), pp.3618-3636.
19. Gautier, J.F. and Ravussin, Y., 2020. A new symptom of COVID‐19: loss of taste and smell. Obesity, 28(5), pp.848-848.
20. Gilbody, S., Littlewood, E., McMillan, D., Chew-Graham, C.A., Bailey, D., Gascoyne, S., Sloan, C., Burke, L., Coventry, P., Crosland, S. and Fairhurst, C., 2021. Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: the BASIL COVID-19 pilot randomised controlled trial. PLoS Medicine, 18(10), p.e1003779.
21. Gu, S., Ślusarczyk, B., Hajizada, S., Kovalyova, I. and Sakhbieva, A., 2021. Impact of the COVID-19 pandemic on online consumer purchasing behavior. Journal of Theoretical and Applied Electronic Commerce Research, 16(6), pp.2263-2281.
22. Hao, F., Tan, W., Jiang, L.I., Zhang, L., Zhao, X., Zou, Y., Hu, Y., Luo, X., Jiang, X., McIntyre, R.S. and Tran, B., 2020. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain, Behavior, and Immunity, 87, pp.100-106.
23. Hasan, N., Rana, R.U., Chowdhury, S., Dola, AJ and Rony, M.K.K., 2021. Ethical considerations in research. Journal of Nursing Research, Patient Safety and Practise (JNRPSP) 2799-1210, 1(01), pp.1-4.
24. Haynes, B.F., Corey, L., Fernandes, P., Gilbert, P.B., Hotez, P.J., Rao, S., Santos, M.R., Schuitemaker, H., Watson, M. and Arvin, A., 2020. Prospects for a safe COVID-19 vaccine. Science Translational Medicine, 12(568), p. eabe0948.
25. Iqbal, M.R. and Chaudhuri, A., 2020. COVID-19: Results of a national survey of United Kingdom healthcare professionals’ perceptions of current management strategy–A cross-sectional questionnaire study. International Journal of Surgery, 79, pp.156-161. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241367/
26. James, A., Plank, M.J., Hendy, S., Binny, R., Lustig, A., Steyn, N., et al., 2021. Successful contact tracing systems for COVID-19 rely on effective quarantine and isolation. PLoS ONE, 16(6), e0252499. https://doi.org/10.1371/journal.pone.0252499
27. Karabulut‐Ilgu, A., Jaramillo Cherrez, N. and Jahren, C.T., 2018. A systematic review of research on the flipped learning method in engineering education. British Journal of Educational Technology, 49(3), pp.398-411.
28. Lovato, A., de Filippis, C. and Marioni, G., 2020. Upper airway symptoms in coronavirus disease 2019 (COVID-19). American Journal of Otolaryngology.
29. Lythgoe, M.P. and Middleton, P., 2020. Ongoing clinical trials for the management of the COVID-19 pandemic. Trends in Pharmacological Sciences, 41(6), pp.363-382.
30. MacIntyre, C.R., 2020. Case isolation, contact tracing, and physical distancing are pillars of COVID-19 pandemic control, not optional choices. The Lancet Infectious Diseases, 20(10), pp.1105-1106.
31. Marini, J.J. and Gattinoni, L., 2020. Management of COVID-19 respiratory distress. JAMA, 323(22), pp.2329-2330.
32. Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., Giattino, C. and Rodés-Guirao, L., 2021. A global database of COVID-19 vaccinations. Nature Human Behaviour, 5(7), pp.947-953.
33. May, C.R., Cummings, A., Myall, M., Harvey, J., Pope, C., Griffiths, P., Roderick, P., Arber, M., Boehmer, K., Mair, F.S. and Richardson, A., 2016. Experiences of long-term life-limiting conditions among patients and carers: what can we learn from a meta-review of systematic reviews of qualitative studies of chronic heart failure, chronic obstructive pulmonary disease and chronic kidney disease?. BMJ Open, 6(10), p.e011694.
34. Mbwogge, M., 2021. Mass testing with contact tracing compared to test and trace for the effective suppression of COVID-19 in the United Kingdom: systematic review. JMIRx med, 2(2), p.e27254.
35. McPherson, K.E., McAloney-Kocaman, K., McGlinchey, E., Faeth, P. and Armour, C., 2021. Longitudinal analysis of the UK COVID-19 psychological wellbeing study: trajectories of anxiety, depression and COVID-19-related stress symptomology. Psychiatry Research, 304, p.114138.
36. Nehme, M., Braillard, O., Alcoba, G., Aebischer Perone, S., Courvoisier, D., Chappuis, F., Guessous, I. and COVICARE TEAM†, 2021. COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Annals of Internal Medicine, 174(5), pp.723-725.
37. Oh, J., Hwang, S., Long, K.Q., Kim, M., Park, K., Kwon, S.L., Artaza Barrios, O.E., Torres, I., Kavanagh, M., Kondo, N. and Kachur, S.P., 2021. Real world evidence of trace, test, isolation, and quarantine impact on the COVID-19 pandemic response performance.
38. Padidar, S., Liao, S.M., Magagula, S., Mahlaba, T.A.A., Nhlabatsi, N.M. and Lukas, S., 2021. Assessment of early COVID-19 compliance to and challenges with public health and social prevention measures in the Kingdom of Eswatini, using an online survey. Plos One, 16(6), p.e0253954.
39. Panovska-Griffiths, J., Kerr, C.C., Stuart, R.M., Mistry, D., Klein, D.J., Viner, R.M. and Bonell, C., 2020. Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study. The Lancet Child & Adolescent Health, 4(11), pp.817-827.
40. Paris Harper-Hardy, M.A., Ruebush, E., Allen, M., Carlin, M., Plescia, M. and Blumenstock, J.S., 2022. COVID-19 case investigation and contact tracing programs and practice: snapshots from the field.
41. Parra, A., Juanes, A., Losada, C.P., Álvarez-Sesmero, S., Santana, V.D., Martí, I., Urricelqui, J. and Rentero, D., 2020. Psychotic symptoms in COVID-19 patients. A retrospective descriptive study. Psychiatry Research, 291, p.113254.
42. Perez Vallejos, E., 2021. Public adoption of and trust in the NHS COVID-19 contact tracing app in the United Kingdom: Quantitative online survey study.
43. Quer, G., Radin, J.M., Gadaleta, M., Baca-Motes, K., Ariniello, L., Ramos, E., Kheterpal, V., Topol, E.J. and Steinhubl, S.R., 2021. Wearable sensor data and self-reported symptoms for COVID-19 detection. Nature Medicine, 27(1), pp.73-77.
44. Remington, R., 2020. Quality appraisal. In A Step-by-step guide to conducting an integrative review (pp. 45-55). Springer, Cham.
45. Rudroff, T., Fietsam, A.C., Deters, J.R., Bryant, A.D. and Kamholz, J., 2020. Post-COVID-19 fatigue: potential contributing factors. Brain Sciences, 10(12), p.1012.
46. Samuel, G. and Lucivero, F., 2021. Bringing ethics into governance: The case of the UK COVID-19 contact tracing app. International Journal of Health Governance.
47. Samuel, G., Roberts, S.L., Fiske, A., Lucivero, F., McLennan, S., Phillips, A., Hayes, S. and Johnson, S.B., 2022. COVID-19 contact tracing apps: UK public perceptions. Critical Public Health, 32(1), pp.31-43.
48. Savtale, S., Hippargekar, P., Bhise, S. and Kothule, S., 2022. Prevalence of otorhinolaryngological symptoms in COVID 19 patients. Indian Journal of Otolaryngology and Head & Neck Surgery, 74(2), pp.3378-3384.
49. Shi, Y., Wang, G., Cai, X.P., Deng, J.W., Zheng, L., Zhu, H.H., Zheng, M., Yang, B. and Chen, Z., 2020. An overview of COVID-19. Journal of Zhejiang University-SCIENCE B, 21(5), pp.343-360.
50. Smith, L.E., Potts, H.W., Amlôt, R., Fear, N.T., Michie, S. and Rubin, G.J., 2021. Adherence to the test, trace, and isolate system in the UK: results from 37 nationally representative surveys. BMJ, 372.
51. Stevanin, S., Palese, A., Bressan, V., Vehviläinen‐Julkunen, K. and Kvist, T., 2018. Workplace‐related generational characteristics of nurses: a mixed‐method systematic review. Journal of Advanced Nursing, 74(6), pp.1245-1263.
52. Wang, H.Y., Li, X.L., Yan, Z.R., Sun, X.P., Han, J. and Zhang, B.W., 2020. Potential neurological symptoms of COVID-19. Therapeutic Advances in Neurological Disorders, 13, p.1756286420917830.
53. Weng, L.M., Su, X. and Wang, X.Q., 2021. Pain symptoms in patients with coronavirus disease (COVID-19): a literature review. Journal of Pain Research, 14, p.147.
54. Williams, J.M., Randle, H. and Marlin, D., 2020. COVID-19: Impact on United Kingdom horse owners. Animals, 10(10), p.1862.
55. Williams, S.N., Armitage, C.J., Tampe, T. and Dienes, K., 2021. Public attitudes towards COVID‐19 contact tracing apps: a UK‐based focus group study. Health Expectations, 24(2), pp.377-385.
56. Yang, L., Liu, S., Liu, J., Zhang, Z., Wan, X., Huang, B., Chen, Y. and Zhang, Y., 2020. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduction and Targeted Therapy, 5(1), pp.1-8.
57. Young, B.C., Eyre, D.W., Kendrick, S., White, C., Smith, S., Beveridge, G., Nonnenmacher, T., Ichofu, F., Hillier, J., Oakley, S. and Diamond, I., 2021. Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial. The Lancet, 398(10307), pp.1217-1229.
58. Yuki, K., Fujiogi, M. and Koutsogiannaki, S., 2020. COVID-19 pathophysiology: a review. Clinical Immunology, 215, p.108427.
59. Zandi, G., Shahzad, I., Farrukh, M. and Kot, S., 2020. Supporting role of society and firms to COVID-19 management among medical practitioners. International Journal of Environmental Research and Public Health, 17(21), p.7961.
60. Zarei, M., Bose, D., Nouri‐Vaskeh, M., Tajiknia, V., Zand, R. and Ghasemi, M., 2022. Long‐term side effects and lingering symptoms post COVID‐19 recovery. Reviews in Medical Virology, 32(3), p.e2289.